Interestingly, these data provide evidence that the LAT1 promoter may be silenced by promoter methylation in gliomas (explaining for the overall low LAT1 protein expression levels) with the degree of promoter methylation appearing even higher in the TCGA low-grade compared to the TCGA GBM cohort. The gene discussed is SLC7A5; the disease is glioma.